PURPOSE: The aim of this study is to investigate the efficacy and safety of 180-W XPS GreenLight laser technology for photoselective prostate vaporization. PATIENTS AND METHODS: A systematic search of the electronic databases was performed. Inclusion criteria were: full-text peer-reviewed journal article, with original data analysis that evaluates the feasibility and the outcome only of 180-W XPS GL laser system. Data at baseline and during follow-up have been taken into account. Intra-operative and postoperative (functional results and complications) data were collected and analyzed. RESULTS: We found 165 articles in our research, among which only nine articles were selected (total 991 patients). A certain grade of variability is present in all the studies in terms of scientific design, sample size and methods of reporting functional results and complications. Nevertheless, a homogenous benefit for patients in terms of symptom score improvement, post-void residual volume reduction and urinary max flow rate improvement was shown. According to Clavien-Dindo classification, 292 (83.7%) adverse events were recorded ≤ grade 2. Adverse events ≥ grade 3 were 57 (16.3%), among which bleeding, urinary retention and residual obstructive tissue represented the wide majority. No mortality was reported. Male sexual function was poorly investigated. CONCLUSIONS: The 180-W XPS GL laser technique is feasible and safe, with a remarkable clinical benefit. Long-term evidence on outcomes and complications are suitable even in the sphere of male sexuality.
PURPOSE: The aim of this study is to investigate the efficacy and safety of 180-W XPS GreenLight laser technology for photoselective prostate vaporization. PATIENTS AND METHODS: A systematic search of the electronic databases was performed. Inclusion criteria were: full-text peer-reviewed journal article, with original data analysis that evaluates the feasibility and the outcome only of 180-W XPS GL laser system. Data at baseline and during follow-up have been taken into account. Intra-operative and postoperative (functional results and complications) data were collected and analyzed. RESULTS: We found 165 articles in our research, among which only nine articles were selected (total 991 patients). A certain grade of variability is present in all the studies in terms of scientific design, sample size and methods of reporting functional results and complications. Nevertheless, a homogenous benefit for patients in terms of symptom score improvement, post-void residual volume reduction and urinary max flow rate improvement was shown. According to Clavien-Dindo classification, 292 (83.7%) adverse events were recorded ≤ grade 2. Adverse events ≥ grade 3 were 57 (16.3%), among which bleeding, urinary retention and residual obstructive tissue represented the wide majority. No mortality was reported. Male sexual function was poorly investigated. CONCLUSIONS: The 180-W XPS GL laser technique is feasible and safe, with a remarkable clinical benefit. Long-term evidence on outcomes and complications are suitable even in the sphere of male sexuality.
Authors: Thomas R W Herrmann; Evangelos N Liatsikos; Udo Nagele; Olivier Traxer; Axel S Merseburger Journal: Eur Urol Date: 2012-01-17 Impact factor: 20.096
Authors: Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas Journal: Eur Urol Date: 2013-11-11 Impact factor: 20.096
Authors: Vincent Misraï; Matthieu Faron; Julien Guillotreau; Eric Bruguière; Benoit Bordier; Shahrokh F Shariat; Morgan Rouprêt Journal: World J Urol Date: 2013-09-26 Impact factor: 4.226
Authors: Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas Journal: J Urol Date: 2014-09-16 Impact factor: 7.450
Authors: Richard Naspro; Alexander Bachmann; Peter Gilling; Rainer Kuntz; Stephan Madersbacher; Francesco Montorsi; Oliver Reich; Christian Stief; Ivano Vavassori Journal: Eur Urol Date: 2009-04-03 Impact factor: 20.096
Authors: Marian S Wettstein; Cédric Poyet; Nico C Grossmann; Christian D Fankhauser; Etienne X Keller; Marko Kozomara; Salome Meyer; Tullio Sulser; Alexander Müller; Thomas Hermanns Journal: World J Urol Date: 2016-01-16 Impact factor: 4.226
Authors: Luca Cindolo; Lorenzo Ruggera; Paolo Destefanis; Claudio Dadone; Giovanni Ferrari Journal: Int Urol Nephrol Date: 2017-01-02 Impact factor: 2.370
Authors: Benoit Peyronnet; Vincent Misrai; Tev Aho; Henry Woo; Thomas Herrmann; Fernando Gomez-Sancha Journal: World J Urol Date: 2017-04-28 Impact factor: 4.226
Authors: Luca Cindolo; Cosimo De Nunzio; Francesco Greco; Paolo Destefanis; Franco Bergamaschi; Giovanni Ferrari; Giuseppe Fasolis; Fabiano Palmieri; Claudio Divan; Rino Oriti; Lorenzo Ruggera; Andrea Tubaro; Claudio Dadone; Gaetano De Rienzo; Antonio Frattini; Vincenzo Mirone; Luigi Schips Journal: World J Urol Date: 2017-11-01 Impact factor: 4.226
Authors: Malek Meskawi; Pierre-Alain Hueber; Roger Valdivieso; Franck Bruyere; Vincent Misrai; Georges Fournier; Ravi Munver; Ganesh Sivarajan; Matthew Rutman; Alexis E Te; Bilal Chughtai; Dean Elterman; Tristan Martel; Mounsif Azizi; Pierre I Karakiewicz; Kevin C Zorn Journal: World J Urol Date: 2017-02-22 Impact factor: 4.226
Authors: Russell N Schwartz; Felix Couture; Iman Sadri; Adel Arezki; David-Dan Nguyen; Ahmed S Zakaria; Kyle Law; Dean Elterman; Malte Rieken; Hannes Cash; Kevin C Zorn Journal: World J Urol Date: 2020-09-15 Impact factor: 4.226
Authors: Khaled Ajib; Mila Mansour; Marc Zanaty; Mansour Alnazari; Pierre-Alain Hueber; Malek Meskawi; Roger Valdivieso; Come Tholomier; Benjamin Pradere; Vincent Misrai; Dean Elterman; Kevin C Zorn Journal: Can Urol Assoc J Date: 2018-03-19 Impact factor: 1.862
Authors: Ghalib Jibara; Daniel D Sjoberg; Gillian L Stearns; Yariv Stabholz; Ali Fathollahi; Laura S Leddy; Nicole Benfante; Behfar Ehdaie; Jonathan A Coleman; James A Eastham; Jaspreet S Sandhu Journal: Urology Date: 2021-02-02 Impact factor: 2.633